Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

LightTyper platform for high-throughput clinical genotyping.

Gurunathan Murugesan1, Kandice Kottke-Marchant, Stephen Ellis

  • 1The Cleveland Clinic Foundation, Department of Clinical Pathology, OH 44195, USA. murugeg@ccf.org

Expert Review of Molecular Diagnostics
|June 7, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Trans-arterial gemcitabine micro perfusion of locally advanced pancreatic cancer enabled by coil plus glue embolization of a pancreaticoduodenal branch.

Radiology case reports·2026
Same author

The BEVATOMOX phase II trial: raltitrexed/oxaliplatin/bevacizumab vs mFOLFOX6/bevacizumab in 2nd-line metastatic colorectal cancer.

The oncologist·2026
Same author

Late Toxicities and Quality of Life After a Radiation Boost for Breast Ductal Carcinoma In Situ: Boost or No Boost in DCIS Randomized Trial.

International journal of radiation oncology, biology, physics·2025
Same author

Impact of Low-Dose Computed Tomography Findings on Cigarette Smoking Cessation Among High-Risk Adults Participating in Lung Cancer Screening.

Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco·2025
Same author

Developments and Controversies in Invasive Diagnosis of Coronary Microvascular Dysfunction in Angina With Nonobstructive Coronary Arteries.

Mayo Clinic proceedings·2024
Same author

Intracoronary Brachytherapy for Drug-Eluting Stent Restenosis: Outcomes and Clinical Correlates.

Journal of the Society for Cardiovascular Angiography & Interventions·2024
Same journal

Artificial intelligence in molecular diagnostics for pandemic preparedness.

Expert review of molecular diagnostics·2026
Same journal

Navigating PD-L1 testing in immuno-oncology: analytical robustness, clinical validation, and the role of the VENTANA SP263 assay.

Expert review of molecular diagnostics·2026
Same journal

Extracellular vesicles as diagnostic and prognostic biomarkers in non-small cell lung cancer.

Expert review of molecular diagnostics·2026
Same journal

Explainable epigenetic aging clocks: an overview of existing AI models and approaches.

Expert review of molecular diagnostics·2026
Same journal

Neuro-axonal injury biomarker serum neurofilament light chain is associated with osteoarthritis: a dual-cohort study from NHANES and UK Biobank.

Expert review of molecular diagnostics·2026
Same journal

Diagnostics and novel laboratory approaches to combat <i>Neisseria gonorrhoeae</i> antimicrobial resistance.

Expert review of molecular diagnostics·2026
See all related articles

Single nucleotide polymorphisms (SNPs) are linked to diseases. The LightTyper platform offers reliable, high-throughput genotyping for clinical applications using melting curve analysis.

Area of Science:

  • Genetics and Molecular Biology
  • Biotechnology
  • Clinical Diagnostics

Background:

  • Single nucleotide polymorphisms (SNPs) are key genetic variations associated with various diseases.
  • Accurate SNP identification and genotyping are crucial for disease research and clinical diagnostics.
  • Existing genotyping platforms vary in throughput and suitability for clinical settings.

Purpose of the Study:

  • To evaluate the LightTyper platform for high-throughput clinical SNP genotyping.
  • To assess the utility of melting curve analysis for SNP identification.
  • To explore the adaptability of existing LightCycler assays for the LightTyper platform.

Main Methods:

  • Utilized the LightTyper platform for SNP identification.
  • Employed melting curve analysis with fluorescently labeled probes.

Related Experiment Videos

  • Developed and validated assays for approximately 100 SNPs in 30 candidate genes, including those associated with myocardial infarction.
  • Tested compatibility with existing LightCycler assays.

    • Main Results:

    • The LightTyper platform demonstrated capability for SNP identification using melting curve analysis.
    • Successful development and validation of assays for a significant number of SNPs.
    • The platform showed amenability to assays developed for the widely used LightCycler system.
    • Initial experience suggests potential for high-throughput clinical genotyping.

    Conclusions:

    • The LightTyper platform shows promise as a robust technology for high-throughput clinical SNP genotyping.
    • Melting curve analysis is an effective method for SNP identification on this platform.
    • Its compatibility with LightCycler assays enhances its clinical utility and adoption potential.